Results of Long-term Therapy of Essential Blepharospasm and Facial Hemispasm with Botulotoxin A;Výsledky Dlhodobej Liečby Esenciálneho Blefarospazmu a Faciálneho Hemispazmu Botulotoxínom A

Ceska a Slovenska Oftalmologie

Volumn 60, Issue 1, 2004, Pages 37-44

  Žiak, Peter ^a  

^a Martinska Fakultna Nemocnica   (Slovakia)

Author keywords

Blepharospasm; Botulotoxin; Hemispasm; Therapy

Indexed keywords

BOTULINUM TOXIN A; MUSCLE RELAXANT AGENT;

ADULT; AGED; ARTICLE; BLEPHAROSPASM; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; HEMIFACIAL SPASM; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; PTOSIS; SIDE EFFECT; FEMALE; MALE; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; BLEPHAROSPASM; BOTULINUM TOXIN TYPE A; FEMALE; HEMIFACIAL SPASM; HUMANS; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS;

EID: 1642527269     PISSN: 12119059     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Ainsworth, J. R., Kraft, S. P.: Long term changes in duration of relief with botulinum toxin treatment of essential blepharospasm and hemifacial spasm. Ophthalmology, 102, 1995, s. 2036-2040.
2. American Academy of Ophthalmology. Ophthalmic Procedures Assessment. Botulinum Toxin Therapy of Eye Muscle Disorders. Safety and Effectiveness. In: Ophthalmology. Instrument and book Issue Sept. 1989, s. 37-41.
3. Bodker, F. S., Olson, J. J., Putterman, A. M.: Acquired blehpharoptosis secondary to essential blepharospasm. Ophthalmic. Surg., 24, 1993, s. 546-550.
4. Elston, J. S.: Long-term results of treatment of idiopathic blepharospasm with botulinum toxin injections. Brit. J. Ophthal., 71, 1987, s. 664-668.
5. Elston, J. S.: The management of blepharospasm and hemifacial spasm. J. Neurol., 239, 1992, s. 5-8.
6. Frech, B. R., Felt, D. P., Wojno, T. H., Munsch, D. C.: Treatment of blepharospasm with botulinum toxin: a preliminary report. Arch. Ophthamol., 102, 1984, s. 1464-1468.
7. Izák, M., Žiak, P.: Liečba blefarospazmu Botulotoxínom A (BOTOX). Vlastné skúsenosti. Choroby hlavy a krku, 10, 1996, s. 17-20.
8. Jankovic, J., Havins, W. E., Wilkins, R. B.: Blinking and blepharospasm, mechanism, diagnosis and management. JAMA, 248, 1982, s. 3160-3164.
9. Jankovic, J., Schwartz, K., Donovan, D. T.: Botulinum toxin Treatment of Cranial-Cervical Dystonia, Spasmodic dysphonia, Other Facial Dystonias and Hemifacial Spasm. J. Neurol. Neurosurg. Psychiatry, 53, 1990, s. 633-639.
10. Jankovic, J., Schwartz, K. S.: Clinical Correlates of response to Botulinum Toxin Injections. Arch. neurol., 48, 1991, s. 1253-1256.
11. Jankovic, J.: Botulinum toxin in movement disorders. Curr. Opin. Neurol., 7, 1994, s. 358-366.
12. Jitpimolmard, S., Tiamkao, S., Laopaiboon, M.: Long term results of botulinum toxin type A (DYSPORT) in the treatment of hemifacial spasm: a report of 175 cases. J. Neurol. Neurosurg. Psychiatry, 64, 1998, s. 751-757.
13. Mauriello, J. A.: Meige's syndrome, and hemifacial spasm: treatment with botulinum toxin. Neurology, 35, 1985, s. 1499-1500.
14. Mauriello, J. A. Jr., Leone, T., Dhillon, S., Pakeman, B., Mostafi, R., Yapez, M. C.: Treatment choices of 119 patients with hemifacial spasm over 11 years. Clin. Neurol. Neurosurg., 98, 1996, s. 213-216.
15. Price, J., O'Day, J.: Efficacy and side effects of botulinum toxin treatment for blepharospasm and hemifacial spasm. Aust. N. Z. J. Ophthalmol., 22, 1994, s. 255-260.
16. Růžička, E., Roth, J., Diblík, P.: Botulotoxin v léčbě blefarospasmu. Prvé zkušenosti. Čas. Lék. čes., 131, 1992, s. 213-216.
17. Scott, A. B., Kennedy, R. A., Stubss, H. A.: Botulinum toxin injection as a treatment for blepharospasm. Arch. Ophthamol., 103, 1985, s. 347-350.
18. Scott, A. B.: Botulinum toxin for blepharospasm. In Spaeth, G. L., Katz, L. J. Current therapy in ophthalmic surgery. Toronto, B. C. Decker, 1989, 355 s.
19. Siatkowski, R. M., Tyutyunikow, A., Biglan, A. W. et al.: Serum Antibody Production to Botulinum A Toxin. Ophthalmology, 100, 1993, s. 1861-1866.
20. Taylor, J. D. N., Kraft, S. P., Kazdan, M. S., Flanders, M., Cadera, W., Orton, R. B.: Treatment blefarospasm and hemifacial spasm with botulinum A toxin: A Canadian multicenter study. Can. J. Ophthalmol., 26, 1991, s. 133-138.
21. Tsoy, E. A., Buckley, A. G., Dutton, J. J.: Treatment of blepharospasm with botulinum toxin. Am. J. Ophthalmol., 103, 1985, s. 176-179.
22. Wang, A., Jankovic, J.: Hemifacial spasm: clinical findings and treatment. Muscle Nerve, 21, 1998, s. 1740-1747.
23. Zuber, M., Sebals, M., Bathien, N. et al.: Botulinum Antibodies in Dystonic Patients Treated With Type A Botulinum Toxin: Frequency and Significance. Neurology, 43, 1993, s. 1715-1718.